0PMJ Stock Chart & Stats
€35.54
€0.37(1.04%)
At close: 4:00 PM EDT
€35.54
€0.37(1.04%)
Day’s Range― - ―
52-Week Range€32.82 - €49.69
Previous CloseN/A
Volume97.96K
Average Volume (3M)313.75K
Market Cap
€41.13B
Enterprise Value€50.98K
Total Cash (Recent Filing)€2.36B
Total Debt (Recent Filing)€15.00B
Price to Earnings (P/E)18.6
Beta1.19
Next Earnings
Nov 05, 2026EPS Estimate
0.68Next Dividend Ex-DateN/A
Dividend Yield2.71%
Share Statistics
EPS (TTM)1.98
Shares Outstanding1,128,000,000
10 Day Avg. Volume473,594
30 Day Avg. Volume313,752
Financial Highlights & Ratios
PEG Ratio2.47
Price to Book (P/B)2.86
Price to Sales (P/S)2.20
P/FCF Ratio22.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€44.26Price Target Upside24.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)2.31
Revenue Forecast (FY)€23.63B
Bulls Say, Bears Say
Bulls Say
Cash FlowFree cash flow was EUR197mn, up 64% y/y, significantly higher than the previous year, supporting continued investment in innovation and shareholder returns.
InnovationSiemens Healthineers is at the forefront of innovation and was the first company to obtain FDA approval for the first photon-counting CT for clinical use and continues to be the only company with such technology commercially available.
Revenue GrowthRevenue grew 6.8% y/y to EUR5.9bn, beating full-year guidance of 5% to 6%.
Bears Say
Diagnostics PerformanceDiagnostics revenue growth was modest and the adjusted EBIT was materially below expectations.
First Mover AdvantageFirst mover advantage may not last long.
Tariffs And Trade BarriersThe adjusted EPS forecast range was widened from EUR2.35 to EUR2.50 originally to EUR2.20 to EUR2.50 to factor in anticipated impacts from tariffs and trade barriers which may affect operations in key markets.
Siemens Healthineers AG News
0PMJ FAQ
What was Siemens Healthineers AG’s price range in the past 12 months?
Siemens Healthineers AG lowest share price was €32.82 and its highest was €49.69 in the past 12 months.
What is Siemens Healthineers AG’s market cap?
Siemens Healthineers AG’s market cap is €41.13B.
When is Siemens Healthineers AG’s upcoming earnings report date?
Siemens Healthineers AG’s upcoming earnings report date is Nov 05, 2026 which is in 91 days.
How were Siemens Healthineers AG’s earnings last quarter?
Siemens Healthineers AG released its earnings results on Jul 31, 2026. The company reported €0.7 earnings per share for the quarter, beating the consensus estimate of €0.529 by €0.171.
Is Siemens Healthineers AG overvalued?
According to Wall Street analysts Siemens Healthineers AG’s price is currently Undervalued.
Does Siemens Healthineers AG pay dividends?
Siemens Healthineers AG pays a Annually dividend of €1 which represents an annual dividend yield of 2.71%. See more information on Siemens Healthineers AG dividends here
What is Siemens Healthineers AG’s EPS estimate?
Siemens Healthineers AG’s EPS estimate is 0.68.
How many shares outstanding does Siemens Healthineers AG have?
Siemens Healthineers AG has 1,128,000,000 shares outstanding.
What happened to Siemens Healthineers AG’s price movement after its last earnings report?
Siemens Healthineers AG reported an EPS of €0.7 in its last earnings report, beating expectations of €0.529. Following the earnings report the stock price went down -0.879%.
Which hedge fund is a major shareholder of Siemens Healthineers AG?
Currently, no hedge funds are holding shares in GB:0PMJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Siemens Healthineers AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€44.26 (24.55% Upside)
€44.26 (24.55% Upside)
Blogger Sentiment
Bullish
GB:0PMJ Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.91%
12-Months-Change
Fundamentals
Return on Equity
2.71%
Trailing 12-Months
Asset Growth
-0.10%
Trailing 12-Months
Company Description
Siemens Healthineers AG
Siemens Healthineers AG, a subsidiary of Siemens Aktiengesellschaft with its headquarters in Erlangen, Germany, is a global leader in medical technology. The company develops, produces, and distributes a comprehensive portfolio of diagnostic and therapeutic products and services, catering to healthcare providers worldwide. Its operations are organized into four distinct business segments. The Imaging segment delivers advanced medical imaging systems, encompassing magnetic resonance imaging (MRI), computed tomography (CT), X-ray technology, molecular imaging, and ultrasound solutions. The Diagnostics segment focuses on providing in-vitro diagnostic products and services for laboratory, molecular, and point-of-care applications, alongside workflow optimization tools and informatics solutions for healthcare facilities. Varian, another key segment, specializes in cancer care, offering cutting-edge technologies, services, and integrated solutions to hospital oncology departments. This includes enhancing workflow efficiency, providing clinical services and consulting, and deploying digital platforms for treatment and therapy management. Lastly, the Advanced Therapies segment supplies sophisticated products designed to facilitate image-guided minimally invasive treatments across various medical fields, such as cardiology, interventional radiology, and surgery. Its offerings include angiography systems, mobile C-arms, and a robotic-assisted platform specifically for endovascular coronary and peripheral vascular procedures. Beyond these core offerings, Siemens Healthineers also provides a suite of essential support services, such as equipment performance management, clinical education and e-learning programs, asset management, managed departmental services for laboratories and healthcare facilities, and expert consulting and digital health services.
0PMJ Company Deck
0PMJ Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call showed a mix of strong operational and product‑led momentum (notably book‑to‑bill strength, Precision Therapy/Varian growth, imaging innovations, radiopharma traction and improved cash/net‑debt) while Diagnostics weakness—driven by China's market rebasing and legacy platform dilution—kept top‑line momentum below prior expectations and led management to lower revenue guidance. Profitability and EPS were supported by tariff refunds and the synergetic core remains on track, but inflation, FX, refinancing and separation costs create tangible near‑term headwinds. Overall the positives around core growth, market share gains, strong orders and cash improvement are materially offset by the Diagnostics decline and macro/one‑off uncertainties, leaving a balanced outlook.View all GB:0PMJ earnings summaries0PMJ Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€44.26
▲(24.55% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Draegerwerk AG & Co. KGaA
―
Eckert & Ziegler Strahlen und Medizintechnik
―
Fresenius Medical Care AG & Co. KGaA
―
Merck KGaA
―
Sartorius
―









